Status:
COMPLETED
Herbal Treatment for Perennial Allergic Rhinitis
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Perennial Allergic Rhinitis
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
Allergic rhinitis(AR) is one of the most common allergic disorders throughout the world.The conventional therapies are effective in alleviating symptoms but the efficacy are limited and not persistent...
Detailed Description
It is a randomized, double-blind, placebo-controlled trial.
Eligibility Criteria
Inclusion
- Aged from 18 to 65 years old
- Have typical symotoms of PAR including rhinirrhea, sneezing, nasal obstruction and itching in nose and eyes for at least 2 previous consecutive years.
- Postive skin prick test(SPT) to hose dust mite, mold, animal dander and cockcroach with regular AR medications withould for 3 days prior to the test
Exclusion
- Pregnant women and women at risk of conception
- Received allergen injections in previous 2 years
- Regular medications for AR or cold and other allergic disorder
- Seasonal allergic rhinitis, vasomotor rhinitis and rhinitis medicamentosa
- Nasal structure deformities, nasal polyps and hypertrophic rhinitis
- Systematic cortisosteroid used within recent 3 months or nasal cortisosteroid with 15 days
- Other active respiratory disorders
- Active medical disorders: cancer, infection, hematology, renal, hepatic, cardiovascular, metabolic and gastrointestinal diseases
Key Trial Info
Start Date :
March 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2006
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT00456755
Start Date
March 1 2004
End Date
April 1 2006
Last Update
January 6 2010
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of ENT, Prince of Wales Hospital
Hong Kong, Hong Kong
2
Department of ENT, Yan Chai Hospital
Hong Kong, Hong Kong